ArticleFrontiers in oncology2022

Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients.

Wen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.